TARA
Protara Therapeutics, Inc.
+0.05 (+1.38%)3.67USD147K成交股數217M市值–本益比(近四季)85.8股價營收比+21.0%營收年增(近四季)2026-11-10下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.5M | – | – | 1.2M | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 17.0M | 13.6M | 9.6M | 10.8M | 9.1M | 9.5M | 8.1M | 6.4M | 7.7M | 6.2M | 7.2M | 5.1M |
| 銷售管理費用 | 6.4M | 6.1M | 5.2M | 5.8M | 5.0M | 4.8M | 4.3M | 4.3M | 4.1M | 4.5M | 4.9M | 4.6M |
| 營業利益 | −23.3M+65% | −19.6M+37% | −14.8M+20% | −16.6M+56% | −14.1M+19% | −14.3M+34% | −12.3M+2% | −10.7M+10% | −11.9M | −10.7M | −12.1M | −9.7M |
| 營業利益率 | -1,575.9% | – | – | -1,356.2% | – | – | – | – | – | – | – | – |
| 稅後淨利 | −21.7M+82% | −17.8M+39% | −13.3M+18% | −15.0M+57% | −11.9M+7% | −12.8M+30% | −11.2M-1% | −9.5M+5% | −11.1M | −9.9M | −11.3M | −9.0M |
| 淨利率 | -1,464.1% | – | – | -1,223.2% | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.36+24% | -0.31+24% | -0.31-38% | -0.35-22% | -0.29-70% | -0.25-71% | -0.50-50% | -0.45-44% | -0.97 | -0.87 | -1.00 | -0.80 |
| 稀釋股數 | 61.0M | 57.5M | 42.3M | 42.3M | 40.7M | 20.6M | 22.3M | 21.2M | 11.4M | 11.3M | 11.3M | 11.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 17.1M | 14.7M | 12.6M | 31.5M | 91.5M | 163M | 51.8M | 89.6M | 52.2M | 33.8M | 34.0M | 21.0M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 176M | 192M | 145M | 157M | 169M | 181M | 94.1M | 102M | 68.1M | 88.5M | 95.1M | 106M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 14.8M | 10.7M | 12.3M | 12.5M | 10.1M | 14.3M | 12.3M | 9.6M | 9.7M | 11.5M | 9.9M | 11.6M |
| 股東權益 | 161M | 181M | 132M | 144M | 158M | 167M | 81.8M | 92.1M | 58.4M | 77.0M | 85.2M | 94.8M |
| 負債比 | 8.4% | 5.6% | 8.5% | 8.0% | 6.0% | 7.9% | 13.1% | 9.4% | 14.3% | 13.0% | 10.4% | 10.9% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −21.3M | – | – | −14.7M+42% | – | – | – | −10.4M | – | – | −12.9M |
| 資本支出 | – | – | – | – | 44K | – | – | – | – | – | – | 6K |
| 自由現金流 | – | – | – | – | −14.8M | – | – | – | – | – | – | −12.9M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | 76K | – | – | 64K |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −57.4M | –% | -1.34 | −56.5M |
| FY2024 | – | – | −44.6M | –% | -2.17 | −35.9M |
| FY2023 | – | – | −40.4M | –% | -3.57 | −37.6M |
| FY2022 | – | – | −66.0M | –% | -5.86 | −26.6M |
| FY2021 | – | – | −47.3M | –% | -4.21 | −35.1M |
| FY2020 | −34K | – | −34.0M | 99,935.3% | -4.70 | −24.3M |
| FY2019 | – | – | −7.8M | –% | -3.04 | −5.5M |
| FY2018 | – | – | −20.7M | –% | -45.80 | −23.4M |